Heidaran M A, Beeler J F, Yu J C, Ishibashi T, LaRochelle W J, Pierce J H, Aaronson S A
Laboratory of Cellular and Molecular Biology, National Cancer Institute, Bethesda, Maryland 20892.
J Biol Chem. 1993 May 5;268(13):9287-95.
Recombinant expression of either the alpha or beta platelet-derived growth factor (PDGF) receptors in 32D hematopoietic cells allows efficient coupling of PDGF with mitogenic and chemotactic signaling pathways inherently expressed by those cells. PDGF-BB stimulation of 32D-alpha R or beta R cells results in anti-P-Tyr recovery of cellular proteins possessing similar as well as distinct phosphotyrosine signals. Comparison of the ability of each receptor to couple with known second messengers revealed that both receptors associated with and/or tyrosine phosphorylated phospholipase C-gamma (PLC gamma) and phosphatidylinositol 3-kinase (p85) with similar stoichiometry. However, the beta platelet-derived growth factor receptor (PDGFR) was significantly more efficient at in vivo tyrosine phosphorylation of GTPase-activating protein (GAP). Similar differences in binding affinity for GAP were observed in NIH/3T3 cells which express both receptors. To quantitate the affinities of each receptor for GAP or PLC gamma, we utilized baculovirus-expressed alpha and beta PDGFRs purified by anti-P-Tyr affinity chromatography. Exposure of immunoblots containing bacterially expressed GAP or PLC gamma to activated alpha or beta PDGF receptors led to a comparable high affinity binding of each receptor to PLC gamma, while the beta PDGFR showed a 5-fold higher binding affinity for GAP. In an effort to correlate differences in their substrate specificities with biological properties of the receptors, we compare their abilities to enhance PDGF-A transforming function in NIH/3T3 cells. Cotransfection of PDGF-A with the alpha PDGFR increased PDGF-A transforming activity by approximately 2-fold. However, cotransfection with a chimeric receptor with the catalytic domain of the beta PDGFR but possessing alpha PDGFR ligand binding properties resulted in 17-fold enhancement of PDGF-A transformation. These findings argue that differences in alpha and beta PDGF receptor substrate specificity in NIH/3T3 fibroblasts correlate with greater transforming activity mediated by the beta PDGFR.
在32D造血细胞中重组表达α或β血小板衍生生长因子(PDGF)受体,可使PDGF与这些细胞固有表达的促有丝分裂和趋化信号通路有效偶联。用PDGF-BB刺激32D-αR或βR细胞,会使具有相似以及不同磷酸酪氨酸信号的细胞蛋白出现抗磷酸酪氨酸(P-Tyr)反应。比较每个受体与已知第二信使偶联的能力发现,两种受体与磷脂酶C-γ(PLCγ)和磷脂酰肌醇3激酶(p85)的结合及/或酪氨酸磷酸化的化学计量相似。然而,β血小板衍生生长因子受体(PDGFR)在体内对GTP酶激活蛋白(GAP)的酪氨酸磷酸化效率明显更高。在表达两种受体的NIH/3T3细胞中也观察到对GAP的结合亲和力存在类似差异。为了定量每个受体对GAP或PLCγ的亲和力,我们利用通过抗磷酸酪氨酸亲和层析纯化的杆状病毒表达的α和βPDGFR。将含有细菌表达的GAP或PLCγ的免疫印迹与活化的α或βPDGF受体接触,导致每个受体与PLCγ具有相当的高亲和力结合,而βPDGFR对GAP的结合亲和力高5倍。为了将它们底物特异性的差异与受体的生物学特性相关联,我们比较了它们在NIH/3T3细胞中增强PDGF-A转化功能的能力。将PDGF-A与αPDGFR共转染可使PDGF-A转化活性增加约2倍。然而,与具有βPDGFR催化结构域但具有αPDGFR配体结合特性的嵌合受体共转染,导致PDGF-A转化增强17倍。这些发现表明,NIH/3T3成纤维细胞中α和βPDGF受体底物特异性的差异与βPDGFR介导的更大转化活性相关。